EVERY YEAR around the world

211 MILLION

People Contract Chlamydia or Gonorrhoea

Only 40.1%

Return their home sampling kits to the lab

1.74 MILLION

Become infertile due to delayed treatment

20+ Days

Time from appointment to treatment

The Problem

STI prevention breaks down because the testing pathway does not match how people actually live. Home-sampling kits require multiple steps, privacy compromises, and the effort of posting samples back to a lab. As a result, a large share of people never complete the process, leaving infections undetected.

For those seeking help in person, the journey is much more difficult. Appointments can take weeks, and treatment is delayed even further. These long timelines turn a simple, treatable infection into a source of anxiety, ongoing transmission, and long-term reproductive harm.

The Solution

LotusDx makes STI testing fast, private, and easy to complete. Using a urine sample, the test provides a clear result within minutes, removing the need to post kits to a lab or wait for a clinic appointment.

Instant answers

Results in 15 minutes

No Clinic

Visit needed to treat chlamydia

1 day

From test to treatment

Meet the Team

Dr. Ali T

CHIEF OPERATING OFFICER

Read Bio
Dr. Parisa Dehghani

CHIEF TECHNOLOGY OFFICER

Read Bio
Mia-J Mandava

CHIEF MEDICAL OFFICER

Read Bio
Dr. Felicity Young

SEXUAL HEALTH ADVISOR

Read Bio

LotusDx in the News

LotusDx Wins Converge

We are proud to announce that we are this year's winner of the Social Impact Prize at Converge 2025. The panel recognized LotusDx's mission to enhance STI testing to have significant impact across the wider society.

Read More
TBAT IC25 Finalist

LotusDx was chosen as 1 of 10 companies amongst 250 applicants to pitch at the 2025 Innovation Challenge hosted by TBAT Innovation. The team walked away with the prize of a trip to CPHI Frankfurt this year, gaining the opportunity to showcase our work globally.

Read More
CANCER RESEARCH HORIZONS

LotusDx was featured as an emerging innovator translating academic research into real-world diagnostics. The article highlighted our early progress, our approach to rapid testing, and the potential impact of our technology on patient care.

Read More